Navigation Links
Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
Date:7/1/2011

ted in patients taking monoamine oxidase inhibitors (MAOIs) or in patients who have taken MAOIs within the preceding 14 days. NUEDEXTA is contraindicated in patients with a known hypersensitivity to its components.

NUEDEXTA may cause serious side effects, including possible changes in heart rhythm. NUEDEXTA is contraindicated in patients with a prolonged QT interval, congenital long QT syndrome or a history suggestive of torsades de pointes, in patients with heart failure as well as patients with, or at risk of, complete atrioventricular (AV) block, unless the patient has an implanted pacemaker.

NUEDEXTA causes dose-dependent QTc prolongation. When initiating NUEDEXTA in patients at risk of QT prolongation and torsades de pointes, electrocardiographic (ECG) evaluation of QT interval should be conducted at baseline and 3-4 hours after the first dose.

The most common adverse reactions in patients taking NUEDEXTA are diarrhea, dizziness, cough, vomiting, weakness, swelling of feet and ankles, urinary tract infection, flu, elevated liver enzymes, and flatulence.

NUEDEXTA may cause dizziness. Precautions to reduce the risk of falls should be taken, particularly for patients with motor impairment affecting gait or a history of falls.

Patients should take NUEDEXTA exactly as prescribed. Patients should not take more than 2 capsules in a 24- hour period, make sure that there is an approximate 12-hour interval between doses, and not take a double dose after they miss a dose.

These are not all the risks from use of NUEDEXTA. For additional important safety information about NUEDEXTA, please see the full Prescribing Information at www.NUEDEXTA.com.

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Forward Looking
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... technology platform company serving the pharmaceutical, biotechnology, ... process development and manufacturing subsidiary Shanghai SynTheAll ... approval from the Japan PMDA for the ... branded commercial drug in July. STA is ...
(Date:8/27/2015)... CAMBRIDGE, Mass. , Aug. 27, 2015 Oryzon ... & Renshaw 17th Annual Global Investment Conference in ... Hotel, ORYZON will be represented by President and CEO ... Dr. Buesa will present this information on Thursday September ... (2nd Floor).  The company is completing preclinical development of its ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 The ... a CAGR of 7.0% between 2014 and 2019. Although ... Computerized Physician Order Entry market, India ... the forecast period in this regional market. The increasing demand ... government bodies for implementation of these systems in healthcare facilities ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 2Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 3
... vitro microbiology and proof of concept in topical ... March 2007 - Arpida Ltd.,(SWX: ARPN) today announced ... against a large panel of,clinical isolates, including those ... of AR-2474 were found,to be highly effective in ...
... Autism Association calls 2006 Pediatrics study fatally,flawed, CHICAGO, ... at a National Autism Association meeting,bolster claims that ... of,autism spectrum disorders. David Ayoub, MD presented data,suggesting ... pervasive developmental disorder (PDD), a form of autism,in ...
Cached Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder 2
(Date:8/27/2015)... ... 27, 2015 , ... Infocast is pleased to announce the ... San Jose, CA. The first event dedicated to finding alternative solutions for ... where battery development and energy storage innovation are concerned. Product developers, designers, ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... Healthpointe ... into its La Tijera Clinic in Los Angeles. Licensed to practice Chinese Needle Therapy ... emphasis on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s La Mirada ...
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores are becoming pet-friendly, ... Amica Insurance is sharing some tips to help your whole family travel safely and ... travel with pets each year. Amica is sharing the following tips from the American ...
(Date:8/27/2015)... ... August 27, 2015 , ... Banc Intranets recently ... The agreement will enable both Johnson City, Tenn.-based firms to work synergistically to promote ... cloud-based safety product that caters to organizations in the financial, commercial and services sectors. ...
(Date:8/27/2015)... Mass. (PRWEB) , ... August 27, 2015 , ... ... Extraction* and high-performance blending all in one machine with the Nutri Ninja® Auto-iQ ... enhanced with next-generation Auto-iQ™ Smooth Boost™ Technology that takes drink customization to a ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4
... Insulet Corporation,(the "Company") (Nasdaq: PODD ) announced today ... aggregate principal amount of convertible senior,notes due 2013 (the ... on Rule 144A under the Securities Act of 1933, ... an option to,purchase up to an additional $10 million ...
... regulators and ... the healthcare industry, LANSDALE, ... appeal process is a big issue facing healthcare reform, says,NAIRO ... While 44 states and Washington, D.C. have external,review laws, each ...
... Headway, LLC (Medical Headway),is pleased to announce ... MedicalHeadway.com, dedicated to arming the public with ... of medicine. The company offers,consumers free and ... cutting-edge,professional medical treatment and product information., ...
... sleep time, even within the normal range, is associated ... naps, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). , ... of California at San Diego, focused on 24 healthy ...
... with Down Syndrome sleep poorly, with more fragmented sleep ... to a research abstract that will be presented on ... the Associated Professional Sleep Societies (APSS). , The study, ... of Michigan, focused on 38 children with Down Syndrome, ...
... are more likely to comply with continuous positive airway ... receive their treatment from a sleep center accredited by ... a research abstract that will be presented on Tuesday ... Associated Professional Sleep Societies (APSS). , The study, authored ...
Cached Medicine News:Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 2Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 3Health News:NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 2Health News:A New Home for Medical Breakthroughs 2Health News:Decreased total sleep time associated with increased REM sleep during subsequent naps 2Health News:Children with Down Syndrome sleep poorly and have more fragmented sleep 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 3
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... The Blue Line UNO Splint fits small, medium, ... cushioned two-part design includes both dorsal and volar ... extension. Recommended for those experiencing symptoms of Carpal ... for busy clinics - stock one splint to ...
Comfort Wrist Immobilizer with thumb abduction. 8"L, soft, padded comfort-type wrist immobilizer with dorsal metal stay. The thumb is held in abduction and splintered with a short metal stay....
Medicine Products: